Stefano M. Santini

2.7k citations

41 papers · 2.2k indexed · 1 hit paper · h-index 21

Co-authors: Filippo Belardelli Caterina Lapenta Mariantonia Logozzi Tiziana Di Pucchio Stefania Parlato Massimo Spada Stefano Fais Simona Donati
Topics: Immunotherapy and Immune Responses (28 papers)Immune Cell Function and Interaction (17 papers)T-cell and B-cell Immunology (15 papers)
Cited by: Immunology Virology Oncology
Journals: The Journal of Experimental Medicine Blood The Journal of Immunology
Partner nations: Italy United States Australia

In The Last Decade

Stefano M. Santini

40 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice

2000 535 citations Stefano M. Santini, Caterina Lapenta et al. profile →

Peers

Countries citing papers authored by Stefano M. Santini

Since Specialization

Citations

This map shows the geographic impact of Stefano M. Santini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefano M. Santini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefano M. Santini more than expected).

Fields of papers citing papers by Stefano M. Santini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefano M. Santini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefano M. Santini. The network helps show where Stefano M. Santini may publish in the future.

Co-authorship network of co-authors of Stefano M. Santini

This figure shows the co-authorship network connecting the top 25 collaborators of Stefano M. Santini. A scholar is included among the top collaborators of Stefano M. Santini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefano M. Santini. Stefano M. Santini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anti-Tumor Immunity to Patient-Derived Breast Cancer Cells by Vaccination with Interferon-Alpha-Conditioned Dendritic Cells (IFN-DC) 2024 ·Vaccines ·Caterina Lapenta,Stefano M. Santini,(unknown),Simona Donati,Serena Cecchetti,(unknown),Piera Catalano,Francesca Urbani,Iole Macchia,Massimo Spada,Sara Vitale,Zuleika Michelini,Domenico Corsi,Ann Zeuner,Rosanna Dattilo,Manuela Tamburo De Bella	0
2	IFN-Alpha-Mediated Differentiation of Dendritic Cells for Cancer Immunotherapy: Advances and Perspectives 2020 ·Vaccines ·Caterina Lapenta,Lucia Gabriele,Stefano M. Santini	17
3	Advances and perspectives of dendritic cell-based active immunotherapies in follicular lymphoma 2020 ·Cancer Immunology Immunotherapy ·Maria Christina Cox,Caterina Lapenta,Stefano M. Santini	10
4	Type I IFN-dependent antibody response at the basis of sex dimorphism in the outcome of COVID-19 2020 ·Cytokine & Growth Factor Reviews ·Lucia Gabriele,Alessandra Fragale,Giulia Romagnoli,Stefania Parlato,Caterina Lapenta,Stefano M. Santini,Keiko Ozato,Imerio Capone	15
5	Lenalidomide improves the therapeutic effect of an interferon-α-dendritic cell-based lymphoma vaccine 2019 ·Cancer Immunology Immunotherapy ·Caterina Lapenta,Simona Donati,Francesca Spadaro,Laura Lattanzi,Francesca Urbani,Iole Macchia,(unknown),Massimo Spada,Maria Christina Cox,Filippo Belardelli,Stefano M. Santini	20
6	Interferon-α-Conditioned Human Monocytes Combine a Th1-Orienting Attitude with the Induction of Autologous Th17 Responses: Role of IL-23 and IL-12 2011 ·PLoS ONE ·Stefano M. Santini,Caterina Lapenta,Simona Donati,Francesca Spadaro,Filippo Belardelli,Maria Ferrantini	57
7	Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cells 2011 ·Vaccine ·Antonella Sistigu,Laura Bracci,Mara Valentini,Enrico Proietti,Roberta Bona,Donatella Negri,Anna Rita Ciccaglione,Elena Tritarelli,Roberto Nisini,Michele Equestre,Angela Costantino,Cinzia Marcantonio,Stefano M. Santini,Caterina Lapenta,Simona Donati,(unknown),(unknown),Andrea Cara,Maurizio Federico	16
8	Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein 2009 ·Virology ·Paola Di Bonito,Felicia Grasso,(unknown),Linda Petrone,Emanuele Fanales‐Belasio,Arianna Mei,(unknown),(unknown),Heinke Conrad,Helga Bernhard,Claudia J. Dembek,Antonio Cosma,Stefano M. Santini,Caterina Lapenta,Simona Donati,Claudia Muratori,Colomba Giorgi,Maurizio Federico	38
9	IFN-alpha in the Generation of Dendritic Cells for Cancer Immunotherapy 2008 ·Handbook of experimental pharmacology ·Stefano M. Santini,Caterina Lapenta,Laura Santodonato,Giuseppina D’Agostino,Filippo Belardelli,Maria Ferrantini	49
10	Differentiation of monocyte‐derived dendritic cells is associated with upregulation and activation of Rac‐1 small GTPase 2006 ·FEBS Letters ·Anna Maria Giammarioli,Lucrezia Gambardella,Maria Giovanna Quaranta,Caterina Lapenta,Stefano M. Santini,Filippo Belardelli,Marina Viora,Walter Malorni	4
11	Controversies in the adjuvant treatment of breast cancer: the role of taxanes 2004 ·Annals of Oncology ·Angelo Di Leo,A. Ciarlo,Massimiliano Panella,Daniele Pozzessere,Stefano M. Santini,(unknown),Laura Biganzoli	7
12	CD2⁺/CD14⁺ monocytes rapidly differentiate into CD83⁺ dendritic cells 2003 ·European Journal of Immunology ·Tiziana Di Pucchio,Caterina Lapenta,Stefano M. Santini,Mariantonia Logozzi,Stefania Parlato,Filippo Belardelli	22
13	The Natural Alliance Between Type I Interferon and Dendritic Cells and Its Role in Linking Innate and Adaptive Immunity 2002 ·Journal of Interferon & Cytokine Research ·Stefano M. Santini,Tiziana Di Pucchio,Caterina Lapenta,Stefania Parlato,Mariantonia Logozzi,Filippo Belardelli	68
14	Primary HIV-1 infection of human CD4+ T cells passaged into SCID mice leads to selection of chronically infected cells through a massive Fas-mediated autocrine suicide of uninfected cells 2000 ·Cell Death and Differentiation ·Stefania Parlato,Stefano M. Santini,Caterina Lapenta,Massimo Spada,Mariantonia Logozzi,Paola Rizza,Enrico Proietti,Filippo Belardelli,Stefano Fais	8
15	Type I Interferon Is a Powerful Inhibitor of in Vivo HIV-1 Infection and Preserves Human CD4+ T Cells from Virus-Induced Depletion in SCID Mice Transplanted with Human Cells 1999 ·Virology ·Caterina Lapenta,Stefano M. Santini,Enrico Proietti,Paola Rizza,Mariantonia Logozzi,Massimo Spada,Stefania Parlato,Stefano Fais,Paula M. Pitha,Filippo Belardelli	42
16	Murine interferon-α1 gene-transduced ESb tumor cells are rejected by host-mediated mechanisms despite resistance of the parental tumor to interferon-α/β therapy 1999 ·Cancer Gene Therapy ·Carmela Rozera,(unknown),Ion Gresser,Marie‐Thérèse Bandu,Enrico Proietti,Massimo Venditti,Paola Sestili,Stefano M. Santini,Stefano Fais,Filippo Belardelli,Maria Ferrantini	6
17	Human intestinal lamina propria lymphocytes are naturally permissive to HIV-1 infection 1999 ·European Journal of Immunology ·Caterina Lapenta,Monica Boirivant,Marco Marini,Stefano M. Santini,Mariantonia Logozzi,Marina Viora,Filippo Belardelli,Stefano Fais	89
18	TREATMENT OF SEVERE COMBINED IMMUNODEFICIENCY MICE WITH ANTI-MURINE GRANULOCYTE MONOCLONAL ANTIBODY IMPROVES HUMAN LEUKOCYTE XENOTRANSPLANTATION1 1998 ·Transplantation ·Stefano M. Santini,Massimo Spada,Stefania Parlato,Mariantonia Logozzi,Caterina Lapenta,Enrico Proietti,Filippo Belardelli,Stefano Fais	16
19	Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-α and HSVtk: perspectives for the generation of cancer vaccines 1997 ·Gene Therapy ·Laura Santodonato,Giuseppina D’Agostino,Stefano M. Santini,Davide Carlei,Piero Musiani,Andrea Modesti,Paola Signorelli,Filippo Belardelli,Maria Ferrantini	19
20	HIV Type 1 Grown on Interferon γ-Treated U937 Cells Shows Selective Increase in Virion-Associated Intercellular Adhesion Molecule 1 and HLA-DR and Enhanced Infectivity for CD4-Negative Cells 1995 ·AIDS Research and Human Retroviruses ·Concetta Castilletti,Maria Rosaria Capobianchi,Stefano Fais,Isabella Abbate,(unknown),F. Ameglio,(unknown),Stefano M. Santini,F. Dianzani	47

About Stefano M. Santini

Stefano M. Santini is a scholar working on Virology, Immunology and Transplantation, having authored 41 papers that have together received 2.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (28 papers), Immune Cell Function and Interaction (17 papers) and T-cell and B-cell Immunology (15 papers). The work is most often cited by research in Immunology (1.8k citations), Virology (356 citations) and Oncology (613 citations). Stefano M. Santini has collaborated with scholars based in Italy, United States and Australia. Frequent co-authors include Filippo Belardelli, Caterina Lapenta, Mariantonia Logozzi, Tiziana Di Pucchio, Stefania Parlato, Massimo Spada, Stefano Fais, Simona Donati, Maria Ferrantini and Enrico Proietti. Their work appears in journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact